Article Details

Atomwise and FutuRx Launch A2i Therapeutics - A New Immuno-Oncology Company Funded By ...

Retrieved on: 2020-12-18 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

Atomwise and FutuRx Launch A2i Therapeutics - A New Immuno-Oncology Company Funded By .... View article details on hiswai:

Excerpt

FutuRx is the leading <b>biotechnology</b> incubator in Israel, established in 2014 by Johnson & Johnson Innovation (JJDC, Inc.), OrbiMed Israel Partners, ...

Article found on: www.manchestertimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up